Desloratadine: Indication, Dosage, Side Effect, Precaution

Generic Medicine Info Full Generic Medicine Info

Dosage/Direction for Use Administration Special Precautions Adverse Reactions Pregnancy Category (US FDA) Drug Interactions Lab Interference Action Storage CIMS Class ATC Classification

This information is not country-specific. Please refer to the India prescribing information.

Generic Medicine Info

Administration

May be taken with or without food.

Special Precautions

Patients with medical or familial history of seizure disorders. Patients who are slow or poor metabolisers of desloratadine may have an increased risk of adverse effects. Renal and hepatic impairment. Children. Pregnancy and lactation. Monitoring Parameters Obtain renal function test and LFT at baseline. Monitor for signs and symptoms of hypersensitivity reactions.

Adverse Reactions

Significant: Increased risk of seizures (particularly in children). Very rarely, hypersensitivity reactions (e.g. anaphylaxis). Gastrointestinal disorders: Dry mouth; diarrhoea (mainly in children <2 years). General disorders and administration site conditions: Fatigue; fever (mainly in children <2 years). Nervous system disorders: Headache. Psychiatric disorders: Insomnia (mainly in children <2 years). Respiratory, thoracic and mediastinal disorders: Pharyngitis; upper respiratory tract infection, cough (mainly in children <2 years).

Pregnancy Category (US FDA)

Drug Interactions

May increase plasma concentrations with ketoconazole, erythromycin, azithromycin, fluoxetine, and cimetidine.

CIMS Class

Antihistamines & Antiallergics

ATC Classification

R06AX27 - desloratadine ; Belongs to the class of other antihistamines for systemic use.

Disclaimer: This information is independently developed by CIMS based on desloratadine from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2023 CIMS. All rights reserved. Powered by CIMSAsia.com